Provided is a package wherein a container has housed therein a pharmaceutical composition which contains a glycolytic enzyme and in which titer reduction resulting from having less amount of said enzyme is inhibited. This package comprises a pharmaceutical composition and a container, wherein: the pharmaceutical composition is a lyophilized formulation that contains a glycolytic enzyme as an active ingredient； and the container houses the pharmaceutical composition and includes, in the inner surface thereof, at least one type of material selected from the group consisting of fine ceramics, silicone resins, and fluorine resins.
